Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01497054 · ClinicalTrials.gov registry record
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 109
- Enrollment target
NCT01497054 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 109 participants.
The verdict
NCT01497054 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if B type natriuretic peptide (BNP) levels can be used to predict a hemodynamically significant patent ductus arteriosus (PDA). This peptide is produced by the ventricles in the heart when they are under stress, such as when a ductus remains open. If we can use a simple and inexpensive blood test to determine whether a PDA needs to be treated, we can potentially treat infants sooner than if they needed to wait for the availability of a cardiologist to perform an echocardiogram. This might decrease some of the deleterious effects of PDAs on the preterm infant such as bronchopulmonary dysplasia, necrotizing enterocolitis, renal hypoperfusion, and pulmonary hemorrhage. In a situation where follow up echocardiogram after a course of medical therapy shows persistent PDA, this test may help to decide whether this baby needs further treatment, either medical or surgical.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01497054
The ClinicalTrials.gov registry entry for NCT01497054 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01497054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01497054 about?
NCT01497054 is a clinical study titled "Do Elevated BNP Levels Predict Hemodynamically Significant PDAs". The purpose of this study is to determine if B type natriuretic peptide (BNP) levels can be used to predict a hemodynamically significant patent ductus arteriosus (PDA). This peptide is produced by the ventricles in the heart when they are under stress, such as when a ductus remains open. If we can ...
What is the current status of trial NCT01497054?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2011-12. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01497054?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.